ArticleThe EMBO journal1993
Targeted disruption of the Oct-2 locus in a B cell provides genetic evidence for two distinct cell type-specific pathways of octamer element-mediated gene activation.
Article in The EMBO journal, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 70 citations in OpenAlex.
- Article
- Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2.Proceedings of the National Academy of Sciences of the United States of America · 2016Article
- Oct2 enhances antibody-secreting cell differentiation through regulation of IL-5 receptor alpha chain expression on activated B cells.The Journal of experimental medicine · 2008Article
- B cell development and immunoglobulin transcription in Oct-1-deficient mice.Proceedings of the National Academy of Sciences of the United States of America · 2004Article
- Mouse lymphoid cell line selected to have high immunoglobulin promoter activity.Molecular and cellular biology · 2002Article
- The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.The American journal of pathology · 2001Article
- The transcription factor, Bright, and immunoglobulin heavy chain expression.Immunologic research · 2001Review
- OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development.The EMBO journal · 1998Article
- Coactivation by OCA-B: definition of critical regions and synergism with general cofactors.Molecular and cellular biology · 1998Article
- Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcription.The EMBO journal · 1997Article
- POU domain transcription factors in embryonic development.Molecular biology reports · 1997Review
- CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2.Molecular and cellular biology · 1996Article
- Gene structure and characterization of the murine homologue of the B cell-specific transcriptional coactivator OBF-1.Nucleic acids research · 1996Article
- Targeted disruption of CD44 in MDAY-D2 lymphosarcoma cells has no effect on subcutaneous growth or metastatic capacity.The Journal of cell biology · 1995Article
- Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B.Molecular and cellular biology · 1995Article
- High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors.The EMBO journal · 1995Article
- Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer.Molecular and cellular biology · 1994Article
- More to learn from gene knockouts.Molecular and cellular biochemistry · 1994Review
- Cloning and functional characterization of LCR-F1: a bZIP transcription factor that activates erythroid-specific, human globin gene expression.Nucleic acids research · 1994Article
- Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities.The EMBO journal · 1994Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
The Oct-2 protein is a tissue-specific POU-homeodomain transcription factor. It has been considered to represent a developmental regulator of immunoglobulin gene expression by virtue of its interaction with a functionally essential octamer element found in immunoglobulin gene promoters. This proposal has been most strongly challenged by several in vitro transcription analyses which have shown that the related ubiquitous factor Oct-1 can activate transcription from immunoglobulin gene promoters as efficiently as Oct-2. We have genetically analyzed Oct-2 function by using gene targeting to disrupt both alleles of the locus in the murine B cell line WEHI-231. This cell line expresses productively rearranged immunoglobulin genes as well as the Oct-2 gene at high levels which are comparable to those observed in activated murine splenic B cells. In spite of a drastic reduction in Oct-2 levels (20-fold), no effect was observed on the expression of endogenous immunoglobulin genes or on the activity of a transfected immunoglobulin promoter or a heterologous promoter with a single octamer element. In contrast, expression of a reporter construct containing multiple octamer motifs upstream of a heterologous promoter was severely reduced in the double-disruptant cells. The differential responses of the single- and multiple-octamer motif reporter constructs in the mutant B cells are unlikely to be a consequence of differing concentration requirements for activation by Oct-2. The two constructs are activated equivalently over the same range of Oct-2 concentration in a non-B cell. These results provide genetic support for the existence of an Oct-2-independent, but octamer element-dependent, B cell-specific pathway for immunoglobulin gene transcription. They also genetically reveal a distinct Oct-2-dependent pathway of octamer-mediated gene activation. This study demonstrates the feasibility of targeting a diploid locus in a somatic mammalian cell line. Extension of this approach to genes encoding other transcription factors will allow a genetic dissection of their functions within the context of cell lines representing various differentiation states.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.